Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
Conditions: Biliary Tract Cancer; Breast Cancer; Cervical Cancer; Colon Cancer; Endometrial Cancer; Esophageal Cancer; Gastric Cancer; GastroEsophageal Cancer; Head and Neck Cancer; Hepatocellular Cancer; Non-small Cell Lung Cancer; Pancreatic Cancer; Prostate Cancer; Rectal Cancer; Renal Cancer; Thyroid Cancer Interventions: Drug: MDX2001 Sponsors: ModeX Therapeutics, An OPKO Health Company Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 2, 2024 Category: Research Source Type: clinical trials
SG and Zimberelimab w/SRS in the Management of Metastatic Triple Negative BCBM
Conditions: Breast Cancer; Triple Negative Breast Cancer Interventions: Radiation: Stereotactic Radiation; Drug: Zimberelimab; Drug: Sacituzumab govitecan Sponsors: H. Lee Moffitt Cancer Center and Research Institute; Gilead Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 2, 2024 Category: Research Source Type: clinical trials
BC Risk Assessment Before Top Surgery
Conditions: Breast Cancer; Risk Reduction Interventions: Diagnostic Test: Breast Cancer Risk Assessment Sponsors: Medical College of Wisconsin Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 2, 2024 Category: Research Source Type: clinical trials
Relationship Between Alterations in the GI Microbiome and GI Inflammation on Symptom Burden in Women With Breast Cancer Receiving Chemotherapy
Conditions: Anatomic Stage I Breast Cancer AJCC v8; Anatomic Stage II Breast Cancer AJCC v8; Anatomic Stage III Breast Cancer AJCC v8 Interventions: Other: Non-Interventional Study Sponsors: Mayo Clinic Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 2, 2024 Category: Research Source Type: clinical trials
First-in-Human Study of OKI-219 in Advanced Solid Tumors and Advanced Breast Cancer
Conditions: Advanced Cancer; Breast Cancer Interventions: Drug: OKI-219; Drug: Fulvestrant; Drug: Trastuzumab Sponsors: OnKure, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 2, 2024 Category: Research Source Type: clinical trials
Biomarkers of Efficacy and Tolerability of Sacituzumab-Govitecan in the Treatment of Patients With Triple-negative Breast Cancer in the Metastatic Phase: Prospective Multicenter Real-world Study
Conditions: Breast Cancer Interventions: Other: data collection Sponsors: Regina Elena Cancer Institute Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 2, 2024 Category: Research Source Type: clinical trials
A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors
Conditions: Metastatic Solid Tumor; Recurrent Solid Tumor; Advanced Solid Tumor; Urinary Bladder Neoplasm; Triple Negative Breast Cancer; Non-small Cell Lung Cancer; Esophageal Cancer; Pancreatic Cancer; Ovarian Cancer; Cervical Cancer; Head and Neck Squamous Cell Carcinoma; Prostate Cancer; Renal Pelvis Cancer; Bladder Cancer Interventions: Drug: LY4101174 Sponsors: Eli Lilly and Company; Loxo Oncology, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 2, 2024 Category: Research Source Type: clinical trials
Sacituzumab Govitecan and Zimberelimab w/SRS in the Management of Metastatic Triple Negative Breast Cancer With Brain Metastases
Conditions: Breast Cancer; Triple Negative Breast Cancer Interventions: Radiation: Stereotactic Radiation; Drug: Zimberelimab; Drug: Sacituzumab govitecan Sponsors: H. Lee Moffitt Cancer Center and Research Institute; Gilead Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 2, 2024 Category: Research Source Type: clinical trials
The Unmet Needs of Cancer Survivors in Ausl IRCCS Reggio Emilia
Conditions: Cancer; Breast Cancer; Prostate Cancer; Thyroid Cancer; Colorectal Cancer; Lymphoma; Multiple Myeloma; Neoplasms Interventions: Other: Focus Groups or Interviews Sponsors: University of Modena and Reggio Emilia; Azienda USL - IRCCS di Reggio Emilia Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 1, 2024 Category: Research Source Type: clinical trials
HR+/HER2- Advanced or Metastatic Breast Cancer Patients Treated With Sacituzumab Govitecan
Conditions: Breast Cancer Stage IV Interventions: Drug: Sacituzumab Govitecan Sponsors: SOLTI Breast Cancer Research Group Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 1, 2024 Category: Research Source Type: clinical trials
Multi-Institutional Transgender & Gender-Diverse Breast Cancer Study
Conditions: Breast Cancer; Breast Neoplasms; Breast Adenocarcinoma; Breast Cancer Stage; Breast Cancer Stage IV; Breast Cancer Invasive; Breast Cancer in Situ Sponsors: Medical College of Wisconsin Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 31, 2024 Category: Research Source Type: clinical trials
Aerobic Dance During Chemotherapy in Breast Cancer Patients With Cognitive Impairment
Conditions: Breast Neoplasms; Exercise Therapy; Chemotherapy-Related Cognitive Impairment; Cognitive Dysfunction; Dance Therapy Interventions: Other: Aerobic dance; Other: Fast-walking Sponsors: The First Affiliated Hospital with Nanjing Medical University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 31, 2024 Category: Research Source Type: clinical trials
Developing Screening Clinical Breast Examination Implementation Strategies in South Africa
Conditions: Breast Cancer Sponsors: Yale University; University of Witwatersrand, South Africa Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 31, 2024 Category: Research Source Type: clinical trials
A Prospective, Open, Multicenter Single-arm Clinical Studie of Docetaxel, Carboplatin Combined With Inetetamab and Pyrotinib in the Treatment of Local-advanced HER2-positive Breast Cancer
Conditions: Breast Neoplasm Female Interventions: Drug: Docetaxel; Drug: Carboplatin; Drug: Inetetamab; Drug: Pyrotinib Sponsors: Wang Ouchen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 31, 2024 Category: Research Source Type: clinical trials
Real World Evaluation of Lunit INSIGHT MMG Technology
Conditions: Breast Cancer; Breast Diseases Interventions: Device: Lunit INSIGHT MMG Sponsors: Lunit Inc.; King ' s College London; The Leeds Teaching Hospitals NHS Trust Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 30, 2024 Category: Research Source Type: clinical trials
